Surgery Partners, Inc. (SGRY)

Every figure this model derived for SGRY, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 70,400,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 216,700,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,126,000,000 AssetsCurrent 2026-06-30
current liabilities 578,500,000 LiabilitiesCurrent 2026-06-30
equity 1,670,700,000 StockholdersEquity 2026-06-30
interest expense 256,800,000 InterestPaidNet 2025-12-31
ocf 258,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,366,300,000 RevenueFromContractWithCustomerIncludingAssessedTax 2026-06-30
sbc 14,800,000 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up SGRY on one particular measure came for.

RatioValue
cash operating margin17.1
current ratio1.95
current ratio reported1.95
dilution pct0.86
ebit cagr3.08
ebit yoy6.14
fcf margin5.57
growth cv0.39
interest cover1.49
net debt ebitda7.91
operating margin11.4
owner earnings margin5.13
revenue growth3.99
revenue growth per share3.11
roic4.96
rule of 4015.4
sbc pct revenue0.44

What to be careful about

What this model itself distrusts about SGRY's figures. Written by the derivation as it ran, not added afterwards.